Browsing by Author Yu, Lingxiang
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
1-Jun-2023 | Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence | Cheng, Jiamin; Chen, Bowen; Zhang, Xinfeng; Su, Guodong; Peng, Caiyun; Lei, Jin; Yu, Lingxiang; Li, Yinyin; Lu, Yinying |
2022 | Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study | Chen, Bowen; Lei, Jin; Zhao, Haitao; Dong, Jinghui; Zeng, Zhen; Li, Yinyin; Yu, Lingxiang; Zhou, Lin; Jia, Aiying; Lu, Yinying; Cheng, Jiamin |
Sep-2022 | Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation | Chen, Wenjia; Ma, Zhaochen; Yu, Lingxiang; Mao, Xia; Ma, Nan; Guo, Xiaodong; Yin, Xiaoli; Jiang, Funeng; Wang, Qian; Wang, Jigang; Fang, Mingliang; Lin, Na; Zhang, Yanqiong |
Feb-2023 | Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients | Yang, Xu; Chen, Bowen; Wang, Yanyu; Wang, Yunchao; Long, Junyu; Zhang, Nan; Xue, Jingnan; Xun, Ziyu; Zhang, Linzhi; Cheng, Jiamin; Lei, Jin; Sun, Huishan; Li, Yiran; Lin, Jianzhen; Xie, Fucun; Wang, Dongxu; Pan, Jie; Hu, Ke; Guan, Mei; Huo, Li; Shi, Jie; Yu, Lingxiang; Zhou, Lin; Zhou, Jinxue; Lu, Zhenhui; Yang, Xiaobo; Mao, Yilei; Sang, Xinting; Lu, Yinying; Zhao, Haitao |